{
    "id": 28287,
    "fullName": "CD274 negative",
    "impact": "unknown",
    "proteinEffect": "loss of function",
    "geneVariantDescriptions": [
        {
            "description": "CD274 negative indicates a lack of the CD274 gene, mRNA, and/or protein.",
            "references": [
                {
                    "id": 275,
                    "pubMedId": null,
                    "title": "External Reference Not Available (N/A)",
                    "url": "https://ckb.jax.org/about/glossaryOfTerms"
                }
            ]
        }
    ],
    "type": "non-specific",
    "gene": {
        "id": 29126,
        "geneSymbol": "CD274",
        "terms": [
            "CD274",
            "B7-H",
            "B7H1",
            "hPD-L1",
            "PD-L1",
            "PDCD1L1",
            "PDCD1LG1",
            "PDL1"
        ]
    },
    "variant": "negative",
    "createDate": "05/24/2018",
    "updateDate": "05/24/2018",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 13947,
            "approvalStatus": "Clinical Study - Cohort",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a clinical study, lung adenocarcinoma patients negative for CD274 and co-harboring a KRAS mutation and TP53 mutation treated with a PD-1 inhibitor demonstrated a greater objective response rate compared to CD274-negative patients harboring either mutant KRAS only or co-harboring a KRAS mutation and STK11 mutation, 30% (3/10) vs 5.9% (1/17) vs 5.3% (1/19), respectively (PMID: 29773717).",
            "molecularProfile": {
                "id": 29888,
                "profileName": "CD274 neg KRAS mut TP53 mut"
            },
            "therapy": {
                "id": 3890,
                "therapyName": "unspecified PD-1 antibody",
                "synonyms": null
            },
            "indication": {
                "id": 3910,
                "name": "lung adenocarcinoma",
                "source": "DOID"
            },
            "responseType": "predicted - sensitive",
            "references": [
                {
                    "id": 11373,
                    "pubMedId": 29773717,
                    "title": "STK11/LKB1 Mutations and PD-1 Inhibitor Resistance in KRAS-Mutant Lung Adenocarcinoma.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/29773717"
                }
            ],
            "ampCapAscoEvidenceLevel": "C",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 17729,
            "approvalStatus": "Phase Ib/II",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a Phase I/II trial, patients with TMB low and CD274 (PD-L1)-negative advanced gastric cancer (n=33) demonstrated worse objective response rate (3.0% vs 33.3%), progression-free survival (1.9 vs 2.7 months), and overall survival (4 vs 12.1 months) compared to patients with TMB high or CD274 (PD-L1)-positive tumors (n=18) in response to Toripalimab (JS001) treatment (PMID: 31236579; NCT02915432).",
            "molecularProfile": {
                "id": 32762,
                "profileName": "CD274 neg TMB low"
            },
            "therapy": {
                "id": 5891,
                "therapyName": "Toripalimab",
                "synonyms": null
            },
            "indication": {
                "id": 10534,
                "name": "stomach cancer",
                "source": "DOID"
            },
            "responseType": "decreased response",
            "references": [
                {
                    "id": 15752,
                    "pubMedId": 31236579,
                    "title": "Safety, efficacy and tumor mutational burden as a biomarker of overall survival benefit in chemo-refractory gastric cancer treated with toripalimab, a PD-1 antibody in phase Ib/II clinical trial NCT02915432.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/31236579"
                }
            ],
            "ampCapAscoEvidenceLevel": "NA",
            "ampCapAscoInferredTier": "NA"
        }
    ],
    "molecularProfiles": [
        {
            "id": 29887,
            "profileName": "CD274 negative",
            "profileTreatmentApproaches": [
                
            ]
        },
        {
            "id": 29888,
            "profileName": "CD274 neg KRAS mut TP53 mut",
            "profileTreatmentApproaches": [
                
            ]
        },
        {
            "id": 32762,
            "profileName": "CD274 neg TMB low",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}